Position of COMT inhibition in the treatment of Parkinson's disease

被引：0
|
作者：
Gordin, AR [1 ]
Kaakkola, T
Teräväinen, H
机构：
[1] Orion Pharma, Res Ctr, Espoo, Finland
[2] Univ Helsinki, Dept Neurol, Helsinki, Finland
来源：
PARKINSON'S DISEASE | 2003年 / 91卷
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：237 / 250
页数：14
相关论文
共 50 条
  • [21] Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerations
    Regensburger, Martin
    Ip, Chi Wang
    Kohl, Zacharias
    Schrader, Christoph
    Urban, Peter P.
    Kassubek, Jan
    Jost, Wolfgang H.
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (06) : 847 - 861
  • [22] First COMT inhibitor approved for Parkinson's disease
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (06) : 524 - +
  • [23] Opicapone (Ongentys) - A COMT Inhibitor for Parkinson's Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1615): : 3 - 5
  • [24] Practical issues with COMT inhibitors in Parkinson's disease
    Waters, C
    NEUROLOGY, 2000, 55 (11) : S57 - S59
  • [25] What is the impact of catechol-O-methyltransferase (COMT) on Parkinson's disease treatment?
    Salamon, Andras
    Zadori, Denes
    Szpisjak, Laszlo
    Klivenyi, Peter
    Vecsei, Laszlo
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (10) : 1123 - 1128
  • [26] Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition
    Cossu, Giovanni
    Ceravolo, Roberto
    Zibetti, Maurizio
    Arca, Roberta
    Ricchi, Valeria
    Paribello, Alessandra
    Murgia, Daniela
    Merola, Aristide
    Romagnolo, Alberto
    Nicoletti, Valentina
    Palermo, Giovanni
    Mereu, Alessandra
    Lopiano, Leonardo
    Melis, Maurizio
    Abbruzzese, Giovanni
    Bonuccelli, Ubaldo
    PARKINSONISM & RELATED DISORDERS, 2016, 27 : 81 - 84
  • [27] Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging
    Ruottinen, HM
    Niinivirta, M
    Bergman, J
    Oikonen, V
    Solin, O
    Eskola, O
    Eronen, E
    Sonninen, P
    Rinne, UK
    SYNAPSE, 2001, 40 (01) : 19 - 26
  • [28] Pain in Parkinson's Disease Associated with COMT Gene Polymorphisms
    Li, Wanjun
    Chen, Yongqian
    Yin, Bowen
    Zhang, Limei
    BEHAVIOURAL NEUROLOGY, 2014, 2014
  • [29] Evidence of COMT dysfunction in the olfactory bulb in Parkinson's disease
    Beauchamp, Leah C.
    Ellett, Laura J.
    Juan, Sydney M. A.
    Liu, Xiang M.
    Hunt, Cameron P. J.
    Parish, Clare L.
    Jacobson, Laura H.
    Shepherd, Claire E.
    Halliday, Glenda M.
    Bush, Ashley I.
    Vella, Laura J.
    Finkelstein, David I.
    Barnham, Kevin J.
    ACTA NEUROPATHOLOGICA, 2025, 149 (01)
  • [30] Simultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease
    Lyytinen, J
    Kaakkola, S
    Ahtila, S
    Tuomainen, P
    Teravainen, H
    MOVEMENT DISORDERS, 1997, 12 (04) : 497 - 505
12345